Saturn V Capital Management »

Celcuity shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 761k 16.38

More positions owned by Saturn V Capital Management

Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Crinetics Pharmaceuticals In (CRNX)
Vaxcyte (PCVX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Cytokinetics Com New (CYTK)
BioMarin Pharmaceutical (BMRN)
Cogent Biosciences (COGT)
Cargo Therapeutics (CRGX)
Kalvista Pharmaceuticals (KALV)
Celcuity (CELC)
Merus N V (MRUS)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Celcuity

BVF
Morgan Stanley
Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Eventide Asset Management
Commodore Capital
BlackRock
Samlyn Capital
NEA Management Company
Soleus Capital Management
Balyasny Asset Management
Partner Fund Management
Saturn V Capital Management
Adage Capital Partners GP

View all funds holding Celcuity